Alexander Pastuszak, MD
Internal Medicine · Salt Lake City, UTNPI 1609020130
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Endo Pharmaceuticals Inc. accounts for 98.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $35,648 and has fallen 99.8% since, to $57 in 2025. Among internal medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $953.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$86K
- Coloplast$555
- Boston Scientific$320
- Innovation Technologies Inc$81
- Metuchen Pharmaceuticals$69
- Endo USA, Inc.$57
- plus $72 from 2 others
Across 10 payments — averaging $11,047 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$100K
- Boston Scientific$10K
What the payments were for
- Consulting fees$29,03833%
- Speaking & faculty fees$48,16556%
- Travel & lodging$6,1387%
- Food & beverage$3,1874%
- Education$2450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 76 | $85,619 |
| Coloplast | 6 | $555 |
| Boston Scientific | 4 | $320 |
| Innovation Technologies Inc | 1 | $81 |
| Metuchen Pharmaceuticals | 1 | $69 |
| Endo USA, Inc. | 1 | $57 |
| Antares Pharma, Inc. | 1 | $50 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$84,541
- TITAN$416
- AMS 700 CXR RTE KIT$113
- TACTRA$111
How this compares
$86,773 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 27 | $1,498 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Salt Lake City
- Willard DereSalt Lake City$4.7M
- James ChamberlainSalt Lake City$106K
- Zameer AbedinSalt Lake City$83K
- Gerald GleichSalt Lake City$22K
- Brian HornerSalt Lake City$21K
- Rachel HessSalt Lake City$18K
- Linda VennerSalt Lake City$8K
- David KuoSalt Lake City$8K
- Evan DaughertySalt Lake City$6K
- Margaret LuntSalt Lake City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.